Annual Gross Profit
$872.34 M
+$218.21 M+33.36%
31 December 2023
Summary:
PTC Therapeutics annual gross profit is currently $872.34 million, with the most recent change of +$218.21 million (+33.36%) on 31 December 2023. During the last 3 years, it has risen by +$510.51 million (+141.09%). PTCT annual gross profit is now at all-time high.PTCT Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$185.94 M
+$14.76 M+8.62%
30 September 2024
Summary:
PTC Therapeutics quarterly gross profit is currently $185.94 million, with the most recent change of +$14.76 million (+8.62%) on 30 September 2024. Over the past year, it has dropped by -$1.15 million (-0.61%). PTCT quarterly gross profit is now -33.10% below its all-time high of $277.94 million, reached on 31 December 2023.PTCT Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$830.43 M
-$1.15 M-0.14%
30 September 2024
Summary:
PTC Therapeutics TTM gross profit is currently $830.43 million, with the most recent change of -$1.15 million (-0.14%) on 30 September 2024. Over the past year, it has increased by +$79.51 million (+10.59%). PTCT TTM gross profit is now -4.80% below its all-time high of $872.34 million, reached on 31 December 2023.PTCT TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTCT Gross Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.4% | -0.6% | +10.6% |
| 3 y3 years | +141.1% | +40.6% | +78.8% |
| 5 y5 years | +246.1% | +171.8% | +191.9% |
PTCT Gross Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +141.1% | -33.1% | +40.6% | -4.8% | +78.8% |
| 5 y | 5 years | at high | +246.1% | -33.1% | +189.7% | -4.8% | +191.9% |
| alltime | all time | at high | +954.8% | -33.1% | +1089.4% | -4.8% | +4295.0% |
PTC Therapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $185.94 M(+8.6%) | $830.43 M(-0.1%) |
| June 2024 | - | $171.18 M(-12.4%) | $831.58 M(-3.5%) |
| Mar 2024 | - | $195.38 M(-29.7%) | $861.48 M(-1.2%) |
| Dec 2023 | $872.34 M(+33.4%) | $277.94 M(+48.6%) | $872.34 M(+16.2%) |
| Sept 2023 | - | $187.08 M(-7.0%) | $750.92 M(-2.1%) |
| June 2023 | - | $201.08 M(-2.5%) | $766.95 M(+6.3%) |
| Mar 2023 | - | $206.24 M(+31.8%) | $721.76 M(+10.3%) |
| Dec 2022 | $654.12 M(+29.2%) | $156.52 M(-22.9%) | $654.12 M(+0.1%) |
| Sept 2022 | - | $203.12 M(+30.3%) | $653.50 M(+12.2%) |
| June 2022 | - | $155.89 M(+12.5%) | $582.59 M(+8.7%) |
| Mar 2022 | - | $138.60 M(-11.1%) | $536.02 M(+5.9%) |
| Dec 2021 | $506.26 M(+39.9%) | $155.90 M(+17.9%) | $506.26 M(+9.0%) |
| Sept 2021 | - | $132.20 M(+20.9%) | $464.34 M(+4.1%) |
| June 2021 | - | $109.32 M(+0.4%) | $445.87 M(+9.7%) |
| Mar 2021 | - | $108.84 M(-4.5%) | $406.49 M(+12.3%) |
| Dec 2020 | $361.82 M | $113.98 M(+0.2%) | $361.82 M(+6.2%) |
| Sept 2020 | - | $113.74 M(+62.6%) | $340.76 M(+15.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $69.94 M(+9.0%) | $295.44 M(-4.0%) |
| Mar 2020 | - | $64.17 M(-30.9%) | $307.81 M(+4.4%) |
| Dec 2019 | $294.85 M(+17.0%) | $92.92 M(+35.8%) | $294.85 M(+3.6%) |
| Sept 2019 | - | $68.41 M(-16.9%) | $284.50 M(+6.8%) |
| June 2019 | - | $82.31 M(+60.7%) | $266.39 M(+6.4%) |
| Mar 2019 | - | $51.21 M(-38.0%) | $250.25 M(-0.7%) |
| Dec 2018 | $252.06 M(+32.8%) | $82.58 M(+64.2%) | $252.06 M(+2.8%) |
| Sept 2018 | - | $50.30 M(-24.0%) | $245.08 M(+4.3%) |
| June 2018 | - | $66.17 M(+24.8%) | $235.05 M(+8.8%) |
| Mar 2018 | - | $53.02 M(-29.9%) | $216.09 M(+14.0%) |
| Dec 2017 | $189.81 M(+129.5%) | $75.59 M(+87.7%) | $189.58 M(+36.2%) |
| Sept 2017 | - | $40.27 M(-14.7%) | $139.17 M(+14.2%) |
| June 2017 | - | $47.20 M(+78.1%) | $121.89 M(+35.0%) |
| Mar 2017 | - | $26.51 M(+5.2%) | $90.32 M(+9.2%) |
| Dec 2016 | $82.70 M | $25.19 M(+9.6%) | $82.70 M(+43.8%) |
| Sept 2016 | - | $22.99 M(+47.0%) | $57.51 M(+66.6%) |
| June 2016 | - | $15.63 M(-17.3%) | $34.53 M(+82.7%) |
| Mar 2016 | - | $18.89 M | $18.89 M |
FAQ
- What is PTC Therapeutics annual gross profit?
- What is the all time high annual gross profit for PTC Therapeutics?
- What is PTC Therapeutics annual gross profit year-on-year change?
- What is PTC Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for PTC Therapeutics?
- What is PTC Therapeutics quarterly gross profit year-on-year change?
- What is PTC Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for PTC Therapeutics?
- What is PTC Therapeutics TTM gross profit year-on-year change?
What is PTC Therapeutics annual gross profit?
The current annual gross profit of PTCT is $872.34 M
What is the all time high annual gross profit for PTC Therapeutics?
PTC Therapeutics all-time high annual gross profit is $872.34 M
What is PTC Therapeutics annual gross profit year-on-year change?
Over the past year, PTCT annual gross profit has changed by +$218.21 M (+33.36%)
What is PTC Therapeutics quarterly gross profit?
The current quarterly gross profit of PTCT is $185.94 M
What is the all time high quarterly gross profit for PTC Therapeutics?
PTC Therapeutics all-time high quarterly gross profit is $277.94 M
What is PTC Therapeutics quarterly gross profit year-on-year change?
Over the past year, PTCT quarterly gross profit has changed by -$1.15 M (-0.61%)
What is PTC Therapeutics TTM gross profit?
The current TTM gross profit of PTCT is $830.43 M
What is the all time high TTM gross profit for PTC Therapeutics?
PTC Therapeutics all-time high TTM gross profit is $872.34 M
What is PTC Therapeutics TTM gross profit year-on-year change?
Over the past year, PTCT TTM gross profit has changed by +$79.51 M (+10.59%)